Excess copper chelating therapy for Wilson disease induces anemia and liver dysfunction

Internal Medicine

Volumn 50, Issue 14, 2011, Pages 1461-1464

  Harada, Masaru ^a   Miyagawa, Koichiro ^a   Honma, Yuichi ^a   Hiura, Masaaki ^a   Shibata, Michihiko ^a   Matsuhashi, Toru ^a   Abe, Shintaro ^a   Harada, Riko ^a   Tabaru, Akinari ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Ceruloplasmin; Chelating therapy; Hemochromatosis; Wilson disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CERULOPLASMIN; COPPER; FERRITIN; TRIENTINE; ZINC ACETATE;

ADULT; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; CASE REPORT; CERULOPLASMIN BLOOD LEVEL; CHELATION THERAPY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DYSARTHRIA; DYSTONIA; FERRITIN BLOOD LEVEL; GAIT DISORDER; HEMOCHROMATOSIS; HUMAN; HYPERSALIVATION; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LONG TERM CARE; LOW DRUG DOSE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; WILSON DISEASE;

ADULT; ANEMIA; CERULOPLASMIN; CHELATING AGENTS; CHELATION THERAPY; COPPER; HEMOCHROMATOSIS; HEPATOLENTICULAR DEGENERATION; HUMANS; IRON; LIVER DISEASES; MALE; TRIENTINE;

EID: 79960505432     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.5209     Document Type: Article

References (27)

1. Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology 47: 2089-2111, 2008.
2. Harada M. Wilson disease. Med Electron Microsc 35: 61-66, 2002.
3. Terada K, Nakako T, Yang XL, et al. Restoration of holoceruloplasmin synthesis in LEC rat after infusion of recombinant adeno virus bearing WND cDNA. J Biol Chem 273: 1815-1820, 1998.
4. Wilson SAK. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain 34: 295-507, 1912.
5. Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 5: 327-337, 1993.
6. Tanzi RE, Petrukhin K, Chernov I, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 5: 344-350, 1993.
7. Yamaguchi Y, Heiny ME, Gitlin JD. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Commun 197: 271-277, 1993.
8. Harada M, Sakisaka S, Terada K, et al. Role of ATP7B in biliary copper excretion in a human hepatoma cell line and normal rat hepatocytes. Gastroenterology 118: 921-928, 2000.
9. Harada M, Kawaguchi T, Kumemura H, et al. The Wilson disease protein ATP7B resides in the late endosomes with Rab7 and the Niemann-Pick C1 protein. Am J Pathol 166: 499-510, 2005.
10. Walshe JM. Wilson's disease. New oral therapy. Lancet 1: 25-26, 1956.
11. Tumer Z, Moller LB. Menkes disease. Eur J Hum Genet 18: 511-518, 2010.
12. Miyajima H, Takahashi Y, Kono S. Aceruloplasminemia, an inherited disorder of iron metabolism. Biometals 16: 205-213, 2003.
13. Texel SJ, Xu X, Harris ZL. Ceruloplasmin in neurodegenerative disease. Biochem Soc Trans 36: 1277-1281, 2008.
14. Miyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda N. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 37: 761-767, 1987.
15. Yoshida K, Furihata K, Takeda S, et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet 9: 267-272, 1995.
16. Harris ZL, Klomp LW, Gitlin JD. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am J Clin Nutr 67: 972S-977S, 1998.
17. Linder MC, Hazegh-Azam M. Copper biochemistry and molecular biology. Am J Clin Nutr 63: 797S-811S, 1996.
18. Yanagimoto C, Harada M, Kumemura H, et al. Niemann-Pick C1 protein transports copper to the secretory compartment from late endosomes where ATP7B resides. Exp Cell Res 315: 119-126, 2009.
19. Kono S, Suzuki H, Takahashi K, et al. Hepatic iron overload associated with a decreased serum ceruloplasmin level in a novel clinical type of aceruloplasminemia. Gastroenterology 131: 240-245, 2006.
20. De Domenico I, Ward DM, di Patti MC, et al. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J 26: 2823-2831, 2007.
21. Pietrangelo A. Hereditary hemochromatosis: Pathogenesis, diagnosis, and treatment. Gastroenterology 139: 393-408, 2010.
22. Shiono Y, Wakusawa S, Hayashi H, et al. Iron accumulation in the liver of male patients with Wilson's disease. Am J Gastroenterol 96: 3147-3151, 2001.
23. Hayashi H, Yano M, Fujita Y, Wakusawa S. Compound overload of copper and iron in patients with Wilson's disease. Med Mol Morphol 39: 121-126, 2006.
24. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090-2093, 2004.
25. Pietrangelo A. Hepcidin in human iron disorders: Therapeutic implications. J Hepatol 54: 173-181, 2011.
26. Condamine L, Hermine O, Alvin P, Levine M, Rey C, Courtecuisse V. Acquired sideroblastic anaemia during treatment of Wilson's disease with triethylene tetramine dihydrochloride. Br J Haematol 83: 166-168, 1993.
27. Perry AR, Pagliuca A, Fitzsimons EJ, Mufti GJ, Williams R. Acquired sideroblastic anaemia induced by a copper-chelating agent. Int J Hematol 64: 69-72, 1996.